UY27310A1 - Composición farmacéutica líquida - Google Patents
Composición farmacéutica líquidaInfo
- Publication number
- UY27310A1 UY27310A1 UY27310A UY27310A UY27310A1 UY 27310 A1 UY27310 A1 UY 27310A1 UY 27310 A UY27310 A UY 27310A UY 27310 A UY27310 A UY 27310A UY 27310 A1 UY27310 A1 UY 27310A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pharmaceutical composition
- pain
- component
- polyhydric alcohol
- composition liquid
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000002193 Pain Diseases 0.000 abstract 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical group NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000005846 sugar alcohols Polymers 0.000 abstract 2
- 208000014644 Brain disease Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composición farmacéutica líquida de análogo de GABA comprendiendo al menos un alcohol polihidroxílico conteniendo 2 a 6 átomos de carbono, que tiene un ph comprendido entre 5,5 a 7.0. Composición farmacéutica líquida en dos componentes comprendiendo un primer componente que comprende una mezcla en polvo que comprende un análogo de GABA y un alcohol polihidroxílico sólido y un segundo componente comprendiendo una base líquida. Métodos para preparar las composiciones y para tratar enfermedades cerebrales, en un amplio espectro, trastornos gastrointestinales, incontinencia, dolor, incluyendo dolor neuropático, dolor muscular, dolor esquelético y migrana.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY27310A UY27310A1 (es) | 2002-05-27 | 2002-05-27 | Composición farmacéutica líquida |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY27310A UY27310A1 (es) | 2002-05-27 | 2002-05-27 | Composición farmacéutica líquida |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27310A1 true UY27310A1 (es) | 2002-12-31 |
Family
ID=38812648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27310A UY27310A1 (es) | 2002-05-27 | 2002-05-27 | Composición farmacéutica líquida |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY27310A1 (es) |
-
2002
- 2002-05-27 UY UY27310A patent/UY27310A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000403A (es) | Composicion farmaceutica liquida | |
| PL347469A1 (en) | Use of certain drugs for treating nerve root injury | |
| GEP20053510B (en) | Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors | |
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| TWI340640B (en) | Combination, kit and pharmaceutical composition for treatment of parkinson's disease | |
| EP2308833A3 (en) | Cyclic protein tyrosine kinase inhibitors | |
| WO2005065195A3 (en) | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
| GEP20074197B (en) | 5ht2c receptor modulators | |
| EA200500169A1 (ru) | Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение | |
| WO2004009549A3 (en) | Piperidines useful for the treatment of central nervous system disorders | |
| BRPI0516105B8 (pt) | material de implante consistindo em fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso, material de implante consistindo em aloenxerto ou colágeno e aloenxerto, método de preparação dos mesmos, uso de fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso na preparação do referido material de implante e uso de aloenxerto ou colágeno e aloenxerto na preparação do referido material de implante | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| EP1670450A4 (en) | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA | |
| ATE231511T1 (de) | Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten | |
| EP2067472A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| SI1569724T1 (sl) | Formulacije, ki vsebujejo melatonin, dvokrpi ginko in biotin | |
| GB2431346B (en) | A combination composition comprising paracetamol and ibuprofen | |
| WO2005034889A3 (en) | Method for imparting artificial tan to human skin | |
| DE50207740D1 (de) | Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs) | |
| DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
| DE60320579D1 (de) | Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen | |
| SI1525188T1 (sl) | Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo | |
| UY27310A1 (es) | Composición farmacéutica líquida | |
| ECSP034853A (es) | Composición farmacéutica líquida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20141217 |